Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAVID J MOONEY

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1831350198
CMS profile
1212878
Location
BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$14,820.01

240 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $8,312.50 5
Food and Beverage $5,248.11 231
Travel and Lodging $1,242.50 3
Education $16.90 1

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
OnMark, Inc. $10,270.94 13
US Oncology Corporate, Inc. $585.59 8
Novartis Pharmaceuticals Corporation $435.52 30
E.R. Squibb & Sons, L.L.C. $265.36 17
Genentech USA, Inc. $197.97 12
Takeda Pharmaceuticals U.S.A., Inc. $186.97 8
PFIZER INC. $184.30 14
CSL Behring $176.54 5
Eisai Inc. $165.24 9
Seagen Inc. $139.46 9
Celgene Corporation $139.00 8
AstraZeneca Pharmaceuticals LP $134.12 8
Regeneron Healthcare Solutions, Inc. $113.47 6
Stemline Therapeutics Inc. $104.82 5
Gilead Sciences, Inc. $101.16 5
Lilly USA, LLC $100.56 6
Janssen Biotech, Inc. $96.98 4
Pharmacyclics LLC, An AbbVie Company $94.35 6
Merck Sharp & Dohme LLC $85.45 4
CTI BioPharma Corp. $79.07 4
Incyte Corporation $76.75 4
Alexion Pharmaceuticals, Inc. $74.47 4
Ipsen Biopharmaceuticals, Inc $65.36 3
GENZYME CORPORATION $62.84 3
Bayer Healthcare Pharmaceuticals Inc. $61.45 3
Daiichi Sankyo Inc. $56.59 3
Mirati Therapeutics, Inc. $51.70 3
Immunocore Limited $45.76 1
HEMA Biologics, LLC $42.14 2
Pharmacosmos Therapeutics Inc. $41.45 2
EMD Serono, Inc. $40.60 2
BeiGene USA, Inc. $40.44 2
Sumitomo Pharma America, Inc. $40.22 2
Amgen Inc. $39.56 2
TAIHO ONCOLOGY, INC. $37.78 2
Kite Pharma, Inc. $36.05 2
Acrotech Biopharma Inc. $33.88 2
Jazz Pharmaceuticals Inc. $23.04 1
Spectrum Pharmaceuticals Inc. $22.34 1
PharmaEssentia USA Corporation $21.52 1
MorphoSys, US Inc. $21.00 1
Coherus Biosciences Inc. $20.47 1
Apellis Pharmaceuticals, Inc. $20.43 1
Myriad Genetic Laboratories, Inc. $20.08 1
Puma Biotechnology, Inc. $19.69 1
Rigel Pharmaceuticals, Inc. $18.99 1
ADC Therapeutics America, Inc. $18.96 1
Karyopharm Therapeutics Inc. $18.16 1
Shield Therapeutics Inc $18.09 1
Deciphera Pharmaceuticals Inc. $17.59 1
Astellas Pharma US Inc $17.38 1
Genmab U.S., Inc. $16.45 1
ABBVIE INC. $15.00 1
Organon LLC $6.91 1

Page 4 of 5; records 151–200 of 240 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DAVID J MOONEY

NPI 1831350198 · CMS profile ID 1212878

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 5; records 151–200 of 240 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1831350198?year=2023&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DAVID J MOONEY, NPI 1831350198, CMS profile ID 1212878. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 5; records 151–200 of 240 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1831350198?year=2023&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). DAVID J MOONEY, NPI 1831350198, CMS profile ID 1212878. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 5; records 151–200 of 240 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1831350198?year=2023&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
DAVID J MOONEY, NPI 1831350198, CMS profile ID 1212878, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 5; records 151–200 of 240 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1831350198?year=2023&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

240 matching records · $14,820.01 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 240 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 240.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Genentech USA, Inc. $17.7204/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040342893 CMS
Incyte Corporation $18.9204/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044570361 CMS
PFIZER INC. $14.1604/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049274055 CMS
PFIZER INC. $4.6904/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049552749 CMS
PFIZER INC. $1.7504/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050401893 CMS
E.R. Squibb & Sons, L.L.C. $14.9504/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015722369 CMS
E.R. Squibb & Sons, L.L.C. $16.9304/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015722365 CMS
Pharmacyclics LLC, An AbbVie Company $13.5804/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998291201 CMS
Eisai Inc. $25.2804/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023307335 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.5704/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055497255 CMS
OnMark, Inc. $350.0004/06/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022497053 CMS
Lilly USA, LLC $19.9404/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031331643 CMS
E.R. Squibb & Sons, L.L.C. $18.4204/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015722361 CMS
Puma Biotechnology, Inc. $19.6904/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059055105 CMS
Amgen Inc. $20.4604/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020563291 CMS
Seagen Inc. $12.8303/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995809769 CMS
E.R. Squibb & Sons, L.L.C. $17.2203/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015722357 CMS
Novartis Pharmaceuticals Corporation $16.7503/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992851025 CMS
Mirati Therapeutics, Inc. $16.8903/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057998075 CMS
Novartis Pharmaceuticals Corporation $14.0203/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992851023 CMS
Regeneron Healthcare Solutions, Inc. $21.1403/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999309581 CMS
Eisai Inc. $17.6503/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023307325 CMS
AstraZeneca Pharmaceuticals LP $14.8103/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015715666 CMS
Kite Pharma, Inc. $17.1303/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025271745 CMS
Novartis Pharmaceuticals Corporation $13.2003/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992850991 CMS
Genentech USA, Inc. $19.0003/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040342863 CMS
Myriad Genetic Laboratories, Inc. $20.0803/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059787899 CMS
TAIHO ONCOLOGY, INC. $19.1103/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055224937 CMS
Organon LLC $6.9103/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1047030613 CMS
Novartis Pharmaceuticals Corporation $16.9703/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992851007 CMS
Novartis Pharmaceuticals Corporation $17.5803/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992851005 CMS
US Oncology Corporate, Inc. $68.6703/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1027222661 CMS
E.R. Squibb & Sons, L.L.C. $15.4003/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015722325 CMS
GENZYME CORPORATION $18.3303/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050126939 CMS
Spectrum Pharmaceuticals Inc. $22.3403/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059885541 CMS
HEMA Biologics, LLC $21.0703/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1028820271 CMS
HEMA Biologics, LLC $21.0703/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051374301 CMS
Ipsen Biopharmaceuticals, Inc $22.7103/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1045431955 CMS
CTI BioPharma Corp. $24.5802/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1039689431 CMS
Gilead Sciences, Inc. $25.9002/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025607877 CMS
OnMark, Inc. $121.6402/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022496891 CMS
PFIZER INC. $15.0002/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049494633 CMS
Celgene Corporation $17.9402/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015722329 CMS
E.R. Squibb & Sons, L.L.C. $19.3702/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015722317 CMS
Novartis Pharmaceuticals Corporation $13.5002/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992851009 CMS
Acrotech Biopharma Inc. $19.6602/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052992287 CMS
Novartis Pharmaceuticals Corporation $15.5902/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992851003 CMS
Pharmacyclics LLC, An AbbVie Company $14.2502/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998291199 CMS
CTI BioPharma Corp. $16.1902/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1039689427 CMS
Novartis Pharmaceuticals Corporation $10.8302/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992851001 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,449.32 267
PY2020 $6,256.69 181
PY2021 $4,607.23 223
PY2022 $7,218.75 284
PY2023 $14,820.01 240
PY2024 $37,254.62 264
PY2025 $45,621.49 259

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $287,999.25 3
PY2024 Principal investigator $673,792.45 1
PY2023 Principal investigator $533,044.15 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Celgene Corporation $16,200.00 10/29/2025 Non-covered Recipient Entity
Central Alabama Research
A Phase 3, Two-part, Randomized, Open-label, Adaptive Study Comparing BMS-986365 versus Investigators Choice of Therapy Comprising Either Docetaxel or Second Androgen Receptor Pathway Inhibitor (ARPI), in Participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) - rechARge No dispute reported 06/30/2026 1222306130
Principal investigator 1 Novartis Pharmaceuticals Corporation $43,271.85 10/28/2025 Non-covered Recipient Entity
HEMATOLOGY AND ONCOLOGY ASSOCIATES OF ALABAMA, LLC
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190301279
Principal investigator 1 AstraZeneca UK Limited $228,527.40 01/13/2025 Non-covered Recipient Entity
CENTRAL ALABAMA RESEARCH
A Phase I-III Randomized Double blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156-AZD3152 for Pre exposure Prophylaxis of COVID 19 in Participants with Conditions Causing Immune Impairment No dispute reported 06/30/2026 1185556025